08.02.2018 13:21:44
|
Navamedic ASA: Invitation to presentation of fourth quarter 2017
Navamedic ASA invites you to a presentation of the fourth quarter 2017 figures. The presentation will take place at Felix Konferansesenter, Aker Brygge, Oslo, Thursday 15 February. The presentation will start at 08.00
The presentation will be webcasted live on www.navamedic.com - investor relations-presentations-webcast at 08.00 CET. Shortly after the presentation the webcast recording will be published on the same site.
Representatives from the Company will be:
CEO Tom Rönnlund
CFO Toril Ås
Contact Navamedic ASA:
Toril Ås
Chief Financial Officer
Mobile: +47 95 70 10 71
E-mail: toril.as@navamedic.com
This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Navamedic ASA via Globenewswire
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Navamedic ASA via Globenewswire

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Navamedic ASAShsmehr Nachrichten
11.02.25 |
Ausblick: Navamedic AS präsentiert das Zahlenwerk zum abgelaufenen Jahresviertel (finanzen.net) | |
28.01.25 |
Erste Schätzungen: Navamedic AS stellt Quartalsergebnis zum abgelaufenen Jahresviertel vor (finanzen.net) | |
30.10.24 |
Ausblick: Navamedic AS vermeldet Zahlen zum jüngsten Quartal (finanzen.net) | |
16.10.24 |
Erste Schätzungen: Navamedic AS informiert über die jüngsten Quartalsergebnisse (finanzen.net) |
Analysen zu Navamedic ASAShsmehr Analysen
Aktien in diesem Artikel
Navamedic ASAShs | 1,80 | -0,55% |
|